NA
Nordic Nano
NANOV.OL·OSEOslo NOFounded 201830 employees
Micro CapbiotechPublicOncology
Platform: NanoTherm Glioma
Market Cap
$0.04B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NANOV.OL)
Loading NANOV.OL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NAN-6418 | NAN-6418 | Phase 2 | 2 | BCMA | PNHAlzheimer's | ||
| NAN-2606 | NAN-2606 | Phase 1 | 2 | EZH2 | BCCT2D |
SEC Filings & Financial Documents
SEC filings are not available for OSE-listed companies.
Nordic Nano trades on OSE (NO). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)